Non-coding recurrent mutations in chronic lymphocytic leukaemia XS Puente, S Beà, R Valdés-Mas, N Villamor, J Gutiérrez-Abril, ... Nature 526 (7574), 519-524, 2015 | 1021 | 2015 |
The genetics and mechanisms of T cell acute lymphoblastic leukaemia L Belver, A Ferrando Nature Reviews Cancer 16 (8), 494-507, 2016 | 463 | 2016 |
A NOTCH1-driven MYC enhancer promotes T cell development, transformation and acute lymphoblastic leukemia D Herranz, A Ambesi-Impiombato, T Palomero, SA Schnell, L Belver, ... Nature medicine 20 (10), 1130-1137, 2014 | 447 | 2014 |
miR-181b negatively regulates activation-induced cytidine deaminase in B cells VG De Yébenes, L Belver, DG Pisano, S Gonzalez, A Villasante, C Croce, ... The Journal of experimental medicine 205 (10), 2199-2206, 2008 | 304 | 2008 |
Metabolic reprogramming induces resistance to anti-NOTCH1 therapies in T cell acute lymphoblastic leukemia D Herranz, A Ambesi-Impiombato, J Sudderth, M Sánchez-Martín, ... Nature medicine 21 (10), 1182-1189, 2015 | 207 | 2015 |
RHOA G17V induces T follicular helper cell specification and promotes lymphomagenesis JR Cortes, A Ambesi-Impiombato, L Couronné, SA Quinn, CS Kim, ... Cancer cell 33 (2), 259-273. e7, 2018 | 197 | 2018 |
MicroRNAs prevent the generation of autoreactive antibodies L Belver, VG de Yébenes, AR Ramiro Immunity 33 (5), 713-722, 2010 | 172 | 2010 |
Common nonmutational NOTCH1 activation in chronic lymphocytic leukemia G Fabbri, AB Holmes, M Viganotti, C Scuoppo, L Belver, D Herranz, ... Proceedings of the National Academy of Sciences 114 (14), E2911-E2919, 2017 | 131 | 2017 |
MicroRNA control of lymphocyte differentiation and function L Belver, FN Papavasiliou, AR Ramiro Current opinion in immunology 23 (3), 368-373, 2011 | 91 | 2011 |
UNG shapes the specificity of AID-induced somatic hypermutation P Pérez-Durán, L Belver, VG de Yébenes, P Delgado, DG Pisano, ... Journal of Experimental Medicine 209 (7), 1379-1389, 2012 | 55 | 2012 |
Therapeutic targeting of HES1 transcriptional programs in T-ALL SA Schnell, A Ambesi-Impiombato, M Sanchez-Martin, L Belver, L Xu, ... Blood, The Journal of the American Society of Hematology 125 (18), 2806-2814, 2015 | 48 | 2015 |
Mutational and functional genetics mapping of chemotherapy resistance mechanisms in relapsed acute lymphoblastic leukemia K Oshima, J Zhao, P Pérez-Durán, JA Brown, JA Patiño-Galindo, T Chu, ... Nature cancer 1 (11), 1113-1127, 2020 | 47 | 2020 |
The genetics and mechanisms of T-cell acute lymphoblastic leukemia F Gianni, L Belver, A Ferrando Cold Spring Harbor Perspectives in Medicine 10 (3), a035246, 2020 | 39 | 2020 |
GATA3-Controlled Nucleosome Eviction Drives MYC Enhancer Activity in T-cell Development and Leukemia L Belver, AY Yang, R Albero, D Herranz, FG Brundu, SA Quinn, ... Cancer discovery 9 (12), 1774-1791, 2019 | 34 | 2019 |
Genomic and epigenomic landscape of juvenile myelomonocytic leukemia C Fiñana, N Gómez-Molina, S Alonso-Moreno, L Belver Cancers 14 (5), 1335, 2022 | 12 | 2022 |
Tcf1 is essential for initiation of oncogenic Notch1-driven chromatin topology in T-ALL M Antoszewski, N Fournier, GA Ruiz Buendía, J Lourenco, Y Liu, ... Blood, The Journal of the American Society of Hematology 139 (16), 2483-2498, 2022 | 10 | 2022 |
Insights into the mechanisms underlying aberrant SOX11 oncogene expression in mantle cell lymphoma R Vilarrasa-Blasi, N Verdaguer-Dot, L Belver, P Soler-Vila, R Beekman, ... Leukemia 36 (2), 583-587, 2022 | 8 | 2022 |
Deregulation of enhancer structure, function, and dynamics in acute lymphoblastic leukemia L Belver, R Albero, AA Ferrando Trends in immunology 42 (5), 418-431, 2021 | 7 | 2021 |
Interplay between UNG and AID governs intratumoral heterogeneity in mature B cell lymphoma P Delgado, ÁF Álvarez-Prado, E Marina-Zárate, IV Sernandez, SM Mur, ... PLoS Genetics 16 (12), e1008960, 2020 | 6 | 2020 |
Aberrant cytokine production by nonmalignant cells in the pathogenesis of myeloproliferative tumors and response to JAK inhibitor therapies L Belver, AA Ferrando Cancer discovery 5 (3), 234-236, 2015 | 6 | 2015 |